Halozyme Therapeutics (HALO) EBIT Margin (2009 - 2026)
Halozyme Therapeutics (HALO) reported EBIT Margin of 59.80% for Q2 2026, down 2.35 percentage points from 62.15% a year earlier but up 10.82 percentage points from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) EBIT Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Halozyme Therapeutics' EBIT Margin came in at 35.90%, down 22.02 percentage points year-over-year; for FY2025, it came in at 33.58%, down 20.73 percentage points from FY2024.
- EBIT Margin has a five-year change of -20.33 percentage points (FY2020 to FY2025).
- By year, EBIT Margin came in at 54.32% in FY2024 (+13.61 pp), 40.71% in FY2023 (+0.18 pp), 40.53% in FY2022 (-21.71 pp) and 62.24% in FY2021 (+8.33 pp).
- Five-year quarterly EBIT Margin spans a low of -20.56% in Q4 2025 and a high of 65.26% in Q3 2021.
- Year over year, EBIT Margin has now declined in each of the last three quarters, with an average year-over-year change of -4.31 percentage points over the last eight quarters.
- The high point for year-over-year EBIT Margin in five years was Q2 2023 (a gain of 20.38 percentage points); the low point was Q4 2025 (a drop of 79.45 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 48.98% (Q1 2026), -20.56% (Q4 2025) and 61.51% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Halozyme Therapeutics | 11.73 Bn | 9.97 Bn | 410.50 Mn | 59.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 59.83% |
| Jun 30, 2026 | 59.80% |
| Mar 31, 2026 | 48.98% |
| Dec 31, 2025 | -20.56% |
| Sep 30, 2025 | 61.51% |
| Jun 30, 2025 | 62.15% |
| Mar 31, 2025 | 53.44% |
| Dec 31, 2024 | 58.89% |
| Sep 30, 2024 | 56.26% |
| Jun 30, 2024 | 50.67% |
| Mar 31, 2024 | 48.78% |
| Dec 31, 2023 | 43.92% |
| Sep 30, 2023 | 40.86% |
| Jun 30, 2023 | 42.73% |
| Mar 31, 2023 | 33.18% |
| Dec 31, 2022 | 41.05% |
| Sep 30, 2022 | 39.86% |
| Jun 30, 2022 | 22.35% |
| Mar 31, 2022 | 64.52% |
| Dec 31, 2021 | 55.42% |
API Access
Halozyme Therapeutics EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();